Gelsolin regulates receptor-mediated and fluid-phase endocytosis in platelets
Journal of Thrombosis and Haemostasis · 2024
DOI: 10.1016/j.jtha.2024.05.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von Manoj Paul und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada; Department of Oral Biological and Medical Sciences, U…. Hauptthemen laut MEDLINE: Blood Platelets, Endocytosis, Gelsolin. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Heart, Lung, and Blood Institute, Michael Smith Health Research BC, Canadian Institutes of Health Research.
Abstract (Originalsprache)
BACKGROUND: Endocytosis is the process by which platelets incorporate extracellular molecules into their secretory granules. Endocytosis is mediated by the actin cytoskeleton in nucleated cells; however, the endocytic mechanisms in platelets are undefined. OBJECTIVES: To better understand platelet endocytosis, we studied gelsolin (Gsn), an actin-severing protein that promotes actin assembly. METHODS: Mouse platelets from Gsn-null (Gsn-/-) and wild-type (WT) controls were used. The uptake of fluorescent cargo molecules was compared as a measure of their endocytic efficiency. Receptor-mediated endocytosis was measured by the uptake of fibrinogen and transferrin; fluid-phase endocytosis was monitored by the uptake of fluorescent dextrans. RESULTS: Adenosine diphosphate (ADP)-stimulated WT platelets readily internalized both receptor-mediated and fluid-phase cargoes. In contrast, Gsn-/- platelets showed a severe defect in the endocytosis of both types of cargo. The treatment of WT platelets with the actin-disrupting drugs cytochalasin D and jasplakinolide also reduced endocytosis. Notably, the individual and combined effects of Gsn deletion and drug treatment were similar for both receptor-mediated and fluid-phase endocytosis, indicating that Gsn mediates endocytosis via its action on the actin cytoskeleton. CONCLUSION: Our study demonstrates that Gsn plays a key role in the uptake of bioactive mediators by platelets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada; Department of Oral Biological and Medical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
- Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada; Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada.
- Versiti Blood Research Institute, Milwaukee, Wisconsin, USA; Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada; Department of Oral Biological and Medical Sciences, University of British Columbia, Vancouver, British Columbia, Canada; De…
Förderung
- National Heart, Lung, and Blood Institute
- Michael Smith Health Research BC
- Canadian Institutes of Health Research
- British Columbia Knowledge Development Fund
- Arthritis Society
- Canada Foundation for Innovation
Zitieren
APA
Paul, M., Hong, F., Falet, H., & Kim, H. (2024). Gelsolin regulates receptor-mediated and fluid-phase endocytosis in platelets. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.05.010
Vancouver
Paul M, Hong F, Falet H, Kim H. Gelsolin regulates receptor-mediated and fluid-phase endocytosis in platelets. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2024.05.010
BibTeX
@article{Paul2024,
author = {Paul, Manoj and Hong, Felix and Falet, Hervé and Kim, Hugh},
title = {Gelsolin regulates receptor-mediated and fluid-phase endocytosis in platelets},
journal = {Journal of Thrombosis and Haemostasis},
year = {2024},
doi = {10.1016/j.jtha.2024.05.010}
}
EUVIMED